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Introduction: Prematurity, a well-established risk factor for various intestinal diseases
in newborns, results in increased morbidity and mortality. However, the intestinal
inflammatory status of preterm (PT) infants has been poorly characterized. Here we have
broadly described the intestinal and systemic inflammatory status of PT children.
Materials and Methods: Meconium and plasma from 39PT and 32 full term (T)
newborns were studied. Fecal calprotectin, polymorphonuclear leukocyte elastase
(PMN-E), TNF, IL-17A, IL-8, IP-10, MCP-1, MIP-1, IL-1β, IL-1α, and E-selectin and
the enzymatic activities of myeloperoxidase (MPO) and alkaline phosphatase (AP) in
meconium were measured. Plasma levels of AP, hepatocyte growth factor, nerve growth
factor (NGF), proinflammatory cytokines, leptin, adiponectin, PAI-1, and resistin were also
determined. Correlations with gestational age (GA) and birth weight (BW) were studied.
Results: Neutrophil derived PMN-E, MPO and calprotectin were increased in the
meconium of PT compared to T newborns, while AP was decreased. No significant
differences were found in other inflammatory parameters. Considering data from all
children, GA and BW showed inverse correlation with neutrophil markers, while AP
directly correlated with BW. Plasma levels of IL-1β and NGF were enhanced in PT infants,
andwere also negatively correlatedwith BW. PT children additionally showed neutropenia
and decreased adiponectin, leptin, haematocrit, and haemoglobin. These parameters
(neutrophils, adiponectin, and so forth) were positively correlated with GA and BW, while
IL-8, MCP-1, PAI-1, and plasma AP were negatively correlated. PT children showing
postnatal morbidity exhibited increased meconium MPO and MIP-1α.
Conclusion: PT neonates present a significant elevation of intestinal inflammatory
parameters, characterized by the presence of neutrophil markers, associated with mild
systemic inflammation.
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INTRODUCTION
Preterm (PT) birth is the leading cause of neonatal mortality
and morbidity worldwide (1). It has been related to intestinal
and immune immaturity. Neonatal meconium, the first stool
of a newborn, accumulates proteins naturally excreted by the
neonate, reflecting not only the neonate status but also the
influence of intrauterine and overall maternal environment
(2). Therefore, the characterization of inflammatory markers
in meconium is a valuable source of information on the state
of the intestine of the newborn, and should relate to the
maturation of both the intestine and the immune system.
Neutrophil derived proteins like calprotectin, PMN-Elastase
(PMN-E), lactoferrin, or myeloperoxidase (MPO) have been
shown to be increased in meconium of newborn infants (3).
Among them, fecal calprotectin has been proposed as a marker
of intestinal inflammation (3–5) and a predictor in the diagnosis
of necrotizing enterocolitis, a severe inflammatory condition, in
PT newborns (6). Although fecal calprotectin has been measured
in feces of PT, only a few studies have specifically assessed it
in the meconium of PT compared to T infants. In this regard,
Lagrogia et al. reported increased levels of calprotectin in the
meconium of preterm infants (7), while a study by Kapel et al.
indicated no differences between PT and T neonates (8). Little is
known about the levels of other leukocyte derived cytokines. On
the other hand, systemic inflammation, in the absence of overt
infection, has been described in the first month of life in PT
children (9, 10), with enhanced circulating levels of IL-6, IL-12,
and granulocyte-colony stimulating factor (G-CSF).
The aim or our study was to characterize and compare
intestinal and systemic inflammatory markers in PT and T
newborns, and to correlate them with gestational age and weight.
Not only neutrophil derived proteins but also other cytokines and
inflammatory markers like alkaline phosphatase (AP) have been
assessed. In addition, the levels of metabolic hormones such as
leptin, adiponectin, or resistin have been studied.
MATERIALS AND METHODS
Study Design
This is a descriptive, analytical, observational case-control study,
which was approved by the Ethical Committee on Human
research of the Reina Sofía University Hospital (Córdoba, Spain).
Neonates were selected after all inclusion criteria were fulfilled
and the informed written consent from the children’s legal
guardians was obtained. Selection criteria and study groups were
as follows. Two groups were established: a group of neonates born
≥37 weeks of gestational age (GA) with birth weight ≥2,500 g
(T group), and a group of neonates born before 37 weeks of
GA (PT group). Children with any congenital malformation or
genetic disease were excluded. Necrotizing enterocolitis was also
excluded. Percentile charts of sex and GA at birth were used to
assign children to PT and T groups (11). A complete evaluation
and physical examination was conducted in all the children.
Perinatal data including the occurrence of chorioamnionitis,
way of delivery, prenatal corticosteroid administration, APGAR,
and fetal pathology were collected. In addition, long term
clinical outcome information was gathered (median follow up
9.2 and 4.7 years for PT and T groups, range 4.5–9.7 and 4.4–
9.7, respectively).
Sample Collection and Routine Parameters
Meconium samples were collected in the first 48 h. Blood samples
(4ml) were drawn and divided in several aliquots. Routine
parameters including haemoglobin, hematocrit, and alkaline
phosphatase (AP) were determined. A blood count was also
performed. All samples not used for routine determinations were
kept at−80◦C until used.
Fecal Parameters
Calprotectin and PMN-E were measured by ELISA
(Immundiagnostik, Bensheim, Germany). MPO and AP
activities measured as described before (12). Supernatants from
meconium homogenized in hexadecyltrimethylammonium
bromide buffer (1:5 w/v) were obtained and TNF, IL-17A,
IL-8, interferon γ-induced protein 10 (IP-10), monocyte
chemoattractant protein 1 (MCP-1), macrophage inflammatory
protein 1 (MIP-1), IL-1β, IL-1α, and E-selectin were assayed
using a human multiplex immunoassay (EPX 200-12185-901,
eBioscience, San Diego, USA) in a group of randomly selected
samples from 22 PT and 27 T infants.
Plasma Inflammatory Parameters
Milliplex Map Human Adipokine Magnetic Beads Panels
HADK1MAG-61K and HADK2MAG-61K from Millipore
(Burlington, USA) were used to determine adiponectin,
plasminogen activator inhibitor 1 (PAI-1) and resistin,
hepatocyte growth factor (HGF), IL-1β, IL-6, IL-8, insulin,
leptin, MCP-1, nerve growth factor (NGF), and TNF.
Sample Size Calculation and Statistical
Analysis
For the calculation of group size we focused on fecal calprotectin
as a reference, which has a standard deviation of 78µg/g (7). To
achieve a statistical power of 0.8 to detect differences of 60µg/g
at alpha= 0.05 it was calculated that n= 28 was required.
All the variables were checked for normality and accordingly
parametric or non-parametric tests were carried out. Differences
were considered statistically significant when p-value (p) was
<0.05. The comparison of means test was the most usual
hypothesis test needed in this study (parametric t-test and
non-parametric Mann-Whitney and Kolmogorov-Sminov tests).
Once the difference between two variables was assumed, the effect
size was assessed by means of the Cohen’s d value following the
standard interpretation (values close to 0.2, 0.5, or 0.8 meaning a
small, medium or large effect). The correlation between variables
was studied calculating the Pearson correlation coefficient, r.
For follow up clinical outcomes data were compared with
Student’s t-test.
RESULTS
Thirty-two T and 39 PT neonates were enrolled in the study. Only
6 mothers of PT infants (15.4%) presented chorioamnionitis.
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FIGURE 1 | Gestational age, birth weight, and inflammatory markers in the meconium of T and PT infants. Birth weight and gestational age of the newborns and
calprotectin, PMN-E, MPO, and AP activity in the feces are shown. +p < 0.05 vs. T.
Eight preterm infants and 18 at term infants were born by
cesarean delivery (20.5 and 56.3%, respectively). APGAR for
preterm infants was lower than that of T infants (mean ± SEM:
6.8 ± 0.3 vs. 8.4 ± 0.2, p < 0.01). Fetal pathology was detected
in 6 PT neonates (15.4%), and 23 presented morbidities that
include respiratory (n = 21, 53.8%), infectious (n = 13, 33.3%),
neurological (n = 9, 23.1%) and haemodynamic/circulatory
(n = 9, 23.1%) involvement. As expected body birth weight
and gestational age were lower in PT vs. T infants (Figure 1).
Both parameters showed a strong correlation in PT children
(Supplementary Table 1) while correlation was weaker in T
children. A correlation between body weight and gestational age
was also observed when data from both groups were studied
together (r = 0.817, p= 0.000).
Preterm Infants Present Mild Intestinal
Inflammation
PT meconium showed a large and medium increase in PMN-
E and MPO compared with T infant levels (Figure 1, Cohen’s
d values 0.773 and 0.369, respectively). Calprotectin was also
increased, with a medium effect (Figure 1, Cohen’s d value =
0.521). All the other inflammatory markers studied were detected
in meconium, although at very low levels in both groups, and no
differences were found (Figure 2). AP activity was moderately
decreased in the meconium of PT infants (Figure 1, Cohen’s
d value = 0.473). Of note, levamisole inhibited AP activity
substantially (more than 99%), indicating that intestinal alkaline
phosphatase was not the predominant isoform present in feces.
In accordance with the notion that gestational age and
weight are related to intestinal inflammation, when PT
and T newborns were analyzed together, gestational age
and/or weight negatively correlated with meconium MPO,
calprotectin and PMN-E levels (Table 1). In turn, AP positively
correlated with birth weight. PT infants showed a slight
positive correlation between body weight and meconium IL-1β
(Supplementary Table 1). As for T newborns, gestational age was
slightly and positively correlated with both meconium IL-1α and
E-selectin and little and negatively with calprotectin and PMN-E
(Supplementary Table 1).
Analyzing data from PT and T infants together, we found a
correlation between calprotectin andMPO (r= 0.363, p= 0.044),
but not with PMN-E. Strong correlations were generally found
among various cytokines (not shown), and between meconium
and plasmatic parameters. For instance, meconium MPO was
correlated with plasma TNF and adiponectin, haemoglobin, and
hematocrit (see Supplementary Table 2 for details).
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FIGURE 2 | Cytokine and adhesion molecules levels in the meconium of T and PT newborns. IL-8, IP-10, IL-1α, E-selectin, IL-17A, MCP-1, MIP-1α, TNF, and IL-1β
are shown. +p < 0.05 vs. T.
Preterm Infants Present Increased
Systemic Inflammatory Markers
Our data indicate that IL-1β was highly increased in the plasma
of PT infants when compared to T newborns (Cohen’s d value =
0.931, Figure 3). NGF and AP in serum were also significantly
augmented, although differences were very small (Cohens’ d
values 0.109 and 0.052, respectively, Figure 3). There was no
correlation in PT children between gestational age or weight and
any of the plasmatic cytokines (Figure 3). In T children a negative
slight correlation was found however between gestational age
and plasma IL-8 (Supplementary Table 1). When data from
all children were considered together, our results indicate that
gestational age and weight were negatively and, in general,
only slightly correlated to circulating IL-8, MCP-1, and AP. In
addition, weight was correlated similarly with IL-1β and NGF
and gestational age with PAI-1 (Table 1).
Although no differences in haemoglobin were found,
haematocrit values were decreased in PT when compared to T
children, suggesting the presence of anemia (Cohen’s d value
= 0.618) (Figure 4). Lower neutrophil counts were observed
in the blood of PT when compared to T newborns (Cohen’s d
value = 1.649). The analysis of correlations of the entire cohort
(i.e., PT and T newborns) indicated positive albeit very small
correlations of gestational age and weight with haemoglobin
and hematocrit, and important correlations with neutrophils
(Table 1). Positive correlations were similarly found in PT infants
(Supplementary Table 1).
Preterm Children Present Lower
Circulating Adiponectin and Leptin Levels
PT children present moderately and importantly lowered levels
of circulating leptin and adiponectin (Cohen’s d values 0.509 and
1.294, respectively, Figure 3). Both adipokines were positively
correlated with gestational age and weight (Table 1).
Clinical Outcomes
The significant clinical outcomes in the follow up of the
newborns is shown inTable 2. As expected, PT exhibited a higher
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TABLE 1 | Correlations of gestational age and birth weight with meconium and plasma parameters.
Gestational age Birth weight
Coeficient, r p-value Coeficient, r p-value
Meconium MPO −0.380 0.002 −0.327 0.007
Calprotectin −0.279 0.033 −0.250 0.051
PMN-E −0.282 0.023 −0.310 0.010
AP n.c n.c 0.275 0.023
Plasma IL-8 −0.246 0.049 −0.248 0.042
MCP1 −0.282 0.023 −0.283 0.050
AP −0.351 0.005 −0.319 0.010
IL-1β n.c. n.c. −0.306 0.011
NGF n.c. n.c. −0.259 0.033
PAI-1 −0.256 0.039 n.c. n.c.
Haemoglobin 0.387 0.001 0.336 0.004
Haematocrit 0.474 0.000 0.391 0.001
Neutrophils 0.743 0.000 0.695 0.000
Leptin 0.268 0.031 0.345 0.004
Adiponectin 0.422 0.000 0.371 0.002
Data from preterm and at term children were analysed together. Only values for statistically significant correlations are shown. Pearson correlation coefficient (r) and p-values are shown.
n.c., no correlation.
FIGURE 3 | Analysis of cytokines, growth factors, inflammatory factors and haematological markers in the plasma of T and PT newborns. TNF, IL-8, IL-6, MCP-1,
IL-1β, NGF, HGF, AP activity, resistin, PAI-1, adiponectin and nectin are shown. +p < 0.05 vs. T.
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FIGURE 4 | Haematological markers in the plasma of T and PT newborns. Haemoglobin, haematocrit, total leukocytes, neutrophils and platelets are shown. +p <
0.05 vs. T.
TABLE 2 | Long term morbidities of PT and T children included in the study.
Morbidities PT T
Gastrointestinal 3 (GER) 4 (x%) (GER)
Respiratory 4 (asthma/BHR) 2 (asthma/BHR)






Others 3 (inguinal hernia)
GER, Gastroesophageal reflux; BHR, bronchial hyperresponsivenes.
morbidity. Interestingly, the group of PT children with at least
one morbidity type exhibited a higher meconium level of MPO
activity (139.9 ± 36.9 vs. 63.3 ± 18.4 mU/mg prot, p = 0.04)
and MIP-1α (273.8 ± 194.2 vs. 20.8 ± 9.0 pg/ml, p = 0.04). In
addition, calprotectin (2449.0 ± 679.7 vs. 1279.1 ± 305.8 mg/kg,
p = 0.07) and blood platelets (275,142 ± 46,077 vs. 201,000 ±
15,462, P = 0.07) just fell short of significance. No differences
were found in the T group.
DISCUSSION
The immaturity of the intestine and the immune system is
a physiological feature of the newborns that, in the case
of premature infants, is specially exacerbated. This fact, in
combination with factors like diet, microbiota colonization or
mode of delivery, has been related to both intestinal and systemic
diseases, including necrotizing enterocolitis or allergies. Despite
these well-established health risks associated with prematurity,
only a few studies have assessed the presence of intestinal
inflammation in preterm children, systemic inflammation having
received more attention (2, 3). Meconium is a valuable source
of information, since proteins accumulated are representative
of the intestinal status and, since it is naturally excreted by the
neonate, it avoids the need for invasive procedures. In this study,
inflammatory biomarkers in meconium samples were measured
in PT and T children. Our data suggest that PT children have
intestinal inflammation, consistent with an increased presence
of neutrophils in meconium, with significantly increased
calprotectin, PMN-E and MPO. Fecal calprotectin is widely
used as a non-specific marker of intestinal inflammation,
particularly in inflammatory bowel disease patients (4), and
has been previously studied in PT infants, with sometimes
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conflictive results, i.e., increased or unchanged levels compared
to T infants (7, 8). PMN-E, MPO and calprotectin have been
previously shown to be correlated in meconium samples (5).
Our results show partial correlation (i.e., calprotectin-MPO but
not with PMN-E). To the best of our knowledge this is the
first study to assess inflammatory markers such as IL-17, IL-
1β, CXCL10, MCP-1, or MIP-1α in PT meconium. The low
expression of these markers corroborates the predominance
of mild neutrophilic inflammation, i.e., neutrophil infiltration
and leakage to the lumen, consistent with acute intestinal
inflammation (6, 7). High sensitivity of AP activity is also
consistent with intestinal inflammation, as it is characteristic
of tissue non-specific rather than intestine type AP (11–13).
Enzyme activity itself was actually decreased, as in previous
reports (13), probably due to gut immaturity or enzyme
instability in an inflammatory context (14). Increased levels
of inflammatory parameters (IL-1β and NGF) are present in
the plasma of PT infants. Given the nature of our study,
these may or may not be related to intestinal inflammation.
Even though global statistical analysis showed no additional
significant differences, it is worth noting that the data obtained
suggest that further effects may be picked up by a study
with increased statistical power. The magnitude of the changes
in inflammatory markers is of course lower than in frank
inflammatory conditions such as necrotizing enterocolitis (8,
15). These findings contrast with the immunological immaturity
expected in PT newborns.
As previously described (16–19), we found neutropenia in PT
children, correlated with weight and gestational age. This can
be secondary to decreased production of neutrophils, increased
neutrophil destruction, or a combination of both mechanisms
(20), consistent with PT leukopenia. Intestinal accumulation
of neutrophils may also contribute, as a secondary transient
cause, given the transitory nature of the phenomenon (7–10
days maximum) (18). Marginal redistribution of neutrophils
produces neutropenia in NEC and inflammatory bowel disease
(21). Other hematological alterations found in our study and
previously described (22, 23) include low hematocrit and
haemoglobin in PT infants. These anomalies were correlated with
gestational age/weight.
We also measured the adipokines leptin, adiponectin, resistin,
and PAI-1. Leptin is considered a proinflammatory adipokine,
and plasma levels are increased in inflammatory bowel disease
(24), while adiponectin is considered anti-inflammatory and
regulated negatively in intestinal inflammation. In spite of its
adipokine character, resistin in humans is actually produced
majoritarily by immune cells (25) and is augmented in
chronic colitis (26). In our study, leptin and adiponectin
levels were reduced in the plasma of PT infants, while
resistin was unchanged. Leptin concentration may be decreased
simply as a consequence of low body weight. Adiponectin
is negatively correlated with adiposity in adulthood, but not
in newborns, suggesting that low plasma levels [consistent
with previous reports (27, 28)] may be accounted for by
mild inflammation. Contrary to other studies (29, 30), we
found similar levels of resistin in PT and T infants. On
the other hand, PAI-1 was augmented, consistent with other
studies in PT infants (31), as well as in term newborns with
low weight (32). Thus, our results indicate a different profile
than in T newborns, with uncertain relation with intestinal
inflammation. Further studies will be required to explore
this possibility.
In order to assess whether our data were correlated in any
way with children’s postnatal morbidity, we gathered information
from the clinical history of the participants. These results should
be interpreted with care as the study is of moderate size and
was not designed for this purpose. Nevertheless, it is noteworthy
that inflammatory parameters in the meconium (MPO, MIP-
1α, and calprotectin, the latter just under significance) were
increased in PT but not in T infants in which gastrointestinal,
respiratory or neurological morbidity occurred. In this regard,
recall bias is not expected to influence data collection within
the PT group. Hence it is of interest to test in a future,
larger study whether such correlation holds and particularly its
prognostic potential.
As mentioned above, the composition of meconium is
influenced not only by the intestinal status but by the
maternal environment. In this regard, it is important to
consider the possible impact of chorioamnionitis, a subclinical
intrauterine infection and/or inflammation that has been
firmly established as a cause of PT delivery (1, 9, 10,
12), as it could partly account for the increased values of
inflammatory parameters in PT meconium. In our study, 6
out of 39 PT infants (15.4%) were born to chorioamnionitis
diagnosed mothers, 3 of them presenting above average
MPO and calprotectin values for this group. When statistical
analysis was carried out excluding these 5 samples, differences
between the PT and T groups remained significant (data
not shown). Thus, chorioamnionitis did not play a major
role in the meconium inflammatory profile observed in
our cohort.
The findings in our study have several limitations,
including the design based on a single time point and
the acknowledged influence of the maternal environment
on the composition of the meconium, beyond the
intestine itself, which may account for the changes
detected. The latter are mitigated by the low and
balanced occurrence of chorioamnionitis in our cohort, as
discussed above.
CONCLUSION
PT infants exhibit signs of acute inflammation in the intestinal
tract with systemic involvement. Adipokine plasma levels are
altered in PT infants, with decreased leptin and adiponectin in
PT newborns.
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